Company profile
Phase Advance
Predicting phase III clinical trial outcomes through in silico models of disease progression with >99% accuracy.
- Industry
- Biotechnology Research
- Employees
- 3
- Headquarters
- Dallas
- Founded
- 2024
- Office locations
- 1
Phase Advance company summary
Phase Advance is a company in the Biotechnology Research industry, headquartered in Dallas, founded in 2024. On LinkedIn the company has around 3 employees. Its listed specialties include Pharmaceutical Development, AI, Clinical Trials, Investment Due Diligence.
What technology does Phase Advance use?
No technologies detected yet. Warmrank rechecks company websites on a rolling basis.
About Phase Advance
We predict future blockbuster drugs today. Our Phase Advance AI™ Programs power complex mathematical models of disease progression in silico to predict individual patient disease trajectory in future phase III trials. We can predict clinical endpoints today, even for drugs that have never entered a single animal or patient. Our lifetime models are layered with non-LLM AI that does not require data to train the model; instead, we need minimal early preclinical inputs to predict drug performance years in advance. We help pharma companies, investors, CROs, and AI drug discovery companies to de-risk drug development, collapse timelines, save millions of dollars, and avoid risk to patients. Biopharma's reliance on animal models has yielded a >90% failure rate for new drugs, but our human-based in silico models of human lifespans have maintained an accuracy rate of >99% when prospectively predicted results are compared to later human trials. We can map out a drug's most successful chance at development by first quantitatively predicting its detailed clinical efficacy in patients. It's time to see the future of drug development.
Specialties
Where is Phase Advance located?
Phase Advance lists 1 location.
Compare companies similar to Phase Advance
More companies in Biotechnology Research.
| Company | Industry | Employees | Founded | Headquarters |
|---|---|---|---|---|
Phase Advance phaseadvance.ai | Biotechnology Research | 3 | 2024 | Dallas |
 Thermo Fisher Scientific thermofisher.com | Biotechnology Research | 100,779 | - | Waltham, MA |
 Amgen amgen.com | Biotechnology Research | 41,028 | 1980 | Thousand Oaks, CA |
 Biogen biogen.com | Biotechnology Research | 7,742 | - | Cambridge, MA |
 Biocon biocon.com | Biotechnology Research | 11,902 | - | Bangalore, Karnataka |
| Biotechnology Research | 28,679 | - | Bethesda, MD | |
 Genentech gene.com | Biotechnology Research | 18,296 | 1976 | South San Francisco, California |
 Eurofins eurofins.com | Biotechnology Research | 24,928 | - | Luxembourg, Luxembourg |
 Gilead Sciences gilead.com | Biotechnology Research | 14,743 | - | Foster City, CA |
 Syneos Health syneoshealth.com | Biotechnology Research | 23,772 | - | Morrisville, NC |
 Moderna modernatx.com | Biotechnology Research | 6,238 | 2010 | Cambridge, Massachusetts |
Frequently asked questions about Phase Advance
What does Phase Advance do?
We predict future blockbuster drugs today. Our Phase Advance AI™ Programs power complex mathematical models of disease progression in silico to predict individual patient disease trajectory in future phase III trials. We can predict clinical endpoints today, even for drugs that have never entered a single animal or patient. Our lifetime models are layered with non-LLM AI that does not require data to train the model; instead, we need minimal early preclinical inputs to predict drug performance years in advance. We help pharma companies, investors, CROs, and AI drug discovery companies to de-risk drug development, collapse timelines, save millions of dollars, and avoid risk to patients. Biopharma's reliance on animal models has yielded a >90% failure rate for new drugs, but our human-based in silico models of human lifespans have maintained an accuracy rate of >99% when prospectively predicted results are compared to later human trials. We can map out a drug's most successful chance at development by first quantitatively predicting its detailed clinical efficacy in patients. It's time to see the future of drug development.
How many employees does Phase Advance have?
Phase Advance has around 3 employees on LinkedIn.
Where is Phase Advance headquartered?
Phase Advance is headquartered in Dallas.
When was Phase Advance founded?
Phase Advance was founded in 2024.
Build a lead list from companies like Phase Advance
Describe your ICP or import a CSV. Warmrank finds matching companies, enriches contacts with verified emails, and tracks every lead.